Tag: life sciences
-
Synthetic Bio Company Acquired in $2.35B Deal
A company developing protein-like therapies for cancer from synthetic bacteria is being acquired by drug maker Sanofi in a deal valued at $2.35 billion.
-
A.I. Harnessed to Detect Cancer Cells
A software package using an image-aided form of machine learning can quickly identify and classify tumor from other cells in lung cancer images.
-
Bioprinting Ear Tissue Tagged Rare Disease Treatment
A company developing 3-D printed outer ear tissue received a rare pediatric disease designation on its treatment designed for children.
-
Once-a-Month Contraceptive Pill Demonstrated
A contraceptive capsule is shown in tests with pigs to release and maintain detectable levels of birth control drugs in the blood stream for up to 29 days.
-
AI-Based Discovery Seeks Non-Opioid Pain Drugs
A new initiative aims to find non-opioid treatments for chronic pain targeting specific nerve cells that initiate pain sensations.
-
Semiconductors Developed to Emulate Nerve Cells
Physicists and neuroscientists created semiconductors that in lab simulations and tests with animal models perform like nerve cells for biological functions.
-
Fine Fibers Spun to Deliver Brain Tumor Treatments
A process for spinning thin polymer fibers loaded with chemotherapy drugs is shown in tests with lab animals to deliver treatments directly to brain tumors.
-
Broad Inst, Biotech Partner on Immune-Safe Crispr
A company designing synthetic proteins and the Broad Institute are developing ways to reduce the threat of edited genes producing an immune-system response.
-
Nature, Merck Establish Science Entrepreneur Prize
The scientific publisher Springer Nature and drug maker Merck are creating an annual award for early-stage companies spun-off from academic research.
-
Trial to Test Engineered Amino Acid for Schizophrenia
A clinical trial plans to test a modified amino acid as an added treatment for schizophrenia that its developers say works differently than most current drugs.